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Research
Cigarette smoking adversely impacts almost 
every organ system of the human body 
[International Agency for Research in Cancer 
(IARC 2004)]. It is a leading risk factor of 
mortality and morbidity in developed and 
developing countries (Ezzati and Lopez 
2003) and is exceedingly costly to societies 
worldwide (Centers for Disease Control and 
Prevention 2002; Yach et al. 2005). Smoking 
has been well established as the principal cause 
of lung cancer (IARC 2004) and the leading 
risk factor for chronic obstructive pulmonary 
disease (Mannino and Buist 2007; Murin 
et al. 2000). Moreover, smoking is increas­
ingly being recognized as a risk factor for a 
wide array of other respiratory illnesses in chil­
dren and adults, including the common cold, 
influenza, asthma, bacterial pneumonia, and 
interstitial lung disease, to name a few (Murin 
et al. 2000). Over 3,000 chemicals, heavy met­
als, and other constituents have been isolated 
from tobacco (IARC 2004), and the over­
whelming majority of studies that have inves­
tigated adverse health impacts associated with 
cigarette smoking have focused on the role of 
these compounds, as well as particulate mat­
ter, on pulmonary and systemic pathophysio­
logic changes that can lead to disease. Few 
studies however, have investigated bacterial 
components of cigarettes and their possible 
roles in smoking­associated illnesses (Bogden 
et al. 1981; Eaton et al. 1995; Hasday et al. 
1999; Kurup et al. 1983; Larsson et al. 2008; 
Morishita 1983; Pauly et al. 2008; Rooney 
et al. 2005; Squires and Hayes 1961).
To date, the studies that have been con­
ducted have used traditional culture­based 
detection methods and have focused on 
only a limited number of microorganisms 
such as Bacillus spp. (Rooney et al. 2005), 
Pantoea spp. (Larsson et al. 2008), Kurthia 
spp. (Rooney et al. 2005), Mycobacterium 
avium (Eaton et al. 1995), and Actinomycetes 
spp. (Kurup et al. 1983). Thus, very little 
is known about the prevalence and diver­
sity of microorganisms in cigarettes. Yet, in 
an era where microbes not only cause acute 
infectious illnesses but also are increasingly 
being recognized as etiologic agents or risk 
factors for chronic diseases including cancers 
(Correa 2003; Hohenberger and Gretschel 
2003; Parsonnet 1995) and neurologic disor­
ders (McKee and Sussman 2005; Schulz et al. 
2006), it is perhaps critical that we further 
our understanding of the bacterial diversity 
of cigarettes, which are used by over 1.2 bil­
lion people (≥ 15 years old) worldwide (IARC 
2004).
In this study, we explored the bacte­
rial metagenome of commercially available 
cigarettes using a 16S rRNA­based taxonomic 
microarray, as well as traditional cloning and 
sequencing methods, to better understand 
bacterial diversity of these widely used prod­
ucts. This is the first study to show that the 
number of microorganisms in cigarettes may 
be as vast as the number of chemical constitu­
ents in these products.
Materials and Methods
Sample collection. In January 2007, cigarettes 
(n = 20 packs) were purchased from five ran­
domly selected tobacco stores in Lyon, France. 
Four cigarette brands were included: Marlboro 
Red (Philip Morris, Inc., Richmond, VA, 
USA), Camel (R.J. Reynolds Tobacco Co., 
Winston­Salem, NC, USA), Kool Filter Kings 
(British American Tobacco Group, London, 
England), and Lucky Strike Original Red 
(British American Tobacco Group, London, 
England). These brands are among the most 
commonly smoked brands of cigarettes in 
Westernized countries and represent three 
major tobacco companies. All of the cigarettes 
were made in the European Union.
DNA extraction. Cigarette packs were 
opened in a sterilized biological safety cabi­
net. Using sterile gloves, five cigarettes from 
each package were dissected, and the tobacco 
from all five cigarettes, equaling 3.5 g, was 
combined in a sterile centrifuge tube. Total 
metagenomic DNA was extracted from each 
tobacco sample using the UltraClean Mega 
Soil DNA Isolation Kit (MoBio Laboratories, 
Inc., Carlsbad, CA, USA). Resulting DNA 
was purified using the NucleoSpin Extract 2 
Kit (Macherey­Nagel Eurl, Hoerdt, France).
Polymerase chain reaction, cloning, and 
sequencing. 16S rRNA genes present in puri­
fied metagenomic DNA were amplified using 
universal primers pA and pH´ (Bruce et al. 
1992) to obtain 16S amplicons representa­
tive of the total bacterial community pres­
ent in the cigarette samples. The pA primer 
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was amended to include T7 promoter for 
subsequent labeling. Primer sequences (5´ to 
3´) were as follows: pA­T7; TAA TAC GAC 
TCA CTA TAG AGA GTT TGA TCC 
TGG CTC AG: pH´; AAG GAG GTG ATC 
CAG CCG CA. The polymerase chain reac­
tion (PCR) mixture yielded a final solution 
containing 1X TITANIUM Taq PCR buffer 
(Clontech Laboratories, Inc., Mountain View, 
CA, USA), 200 µM deoxynucleotide triphos­
phates, 0.5 µM of each primer, 1.5 units of 
TITANIUM Taq, and approximately 150 ng 
metagenomic DNA. Purified metagenomic 
soil DNA and molecular­grade water were 
used as positive and negative controls, respec­
tively. Thermal cycling conditions were as fol­
lows: 94°C for 3 min; 35 cycles of 94°C for 
45 sec, 55°C for 45 sec, 72°C for 90 sec; and a 
final extension at 72°C for 5 min. Results were 
visualized by gel electrophoresis. Gel bands 
of 16S amplicons (1,500 bp) were extracted 
using sterilized blades and purified using the 
GFX PCR DNA and Gel Band Purification 
Kit (GE Healthcare, Piscataway, NJ, USA). 
All PCR reactions were prepared in a sterilized 
biological safety cabinet, and all amplicons 
were analyzed in a dedicated post­PCR area.
Purified 16S amplicons from one of the 
Marlboro Red metagenomic samples were 
cloned for sequencing using a TOPO TA 
cloning kit (Invitrogen, Cergy Pontoise, 
France) with a pCR4 TOPO vector and 
One Shot TOP10 electrocompetent cells 
(Invitrogen). Resulting colonies (n = 288) 
were isolated and analyzed to check for posi­
tive clones and to choose clones with different 
restriction profiles. Each colony was inocu­
lated in 100 µL LB containing 100 µg/mL 
ampicillin and grown overnight at 37°C. One 
microliter of each overnight culture was used 
for a subsequent PCR reaction. Amplification 
was performed with the universal M13 
reverse and M13 forward primer pairs using a 
Platinum PCR SuperMix 96 (Invitrogen).
Each amplification product was digested 
by EcoRI, and restriction profiles were 
observed by gel electrophoresis. Positive clones 
(n = 96) were selected and sequenced with the 
M13 primers by the ABI3730x/DNA Analyzer 
system (Cogenics, Meylan, France). The DNA 
sequences were analyzed by Lasergene 7.2 soft­
ware (DNAStar Inc., Madison, WI, USA). For 
identification of closest relatives, the consensus 
sequences were compared with 16S rRNA 
gene sequences in GenBank databases using 
the NCBI Blast search tool (National Center 
for Biotechnology Information 2009).
Labeling and sample preparation. Purified 
16S amplicons from all samples were reverse­
transcribed and labeled with UTP­Cy3. The 
reaction mixture yielded a final solution of 
1X T7 RNA buffer; 10 mM DTT; 0.5 mM 
concentrations of dATP, dCTP, dGTP, and 
dUTP; 20 units of RNasin (Invitrogen), 1 
µL T7 RNA polymerase (Invitrogen), 0.25 
mM UTP­Cy3, and 400 ng purified PCR 
amplicons. Each reaction mixture was incu­
bated in the dark at 37°C for 4 hr. Resulting 
RNA was purified using the RNeasy Mini Kit 
(Qiagen, Valencia, CA, USA). Purified RNA 
was then quantified, and frequency of incor­
poration (FOI) of Cy3 was calculated: FOI 
of Cy3 = (OD550/0.15)*(324)/OD260*40). 
Purified RNA was then fragmented in a reac­
tion mixture yielding a final solution of 25 
µM Tris Cl and 10 mM ZnSO4. The frag­
mentation reactions were incubated for 30 
min at 60°C, and 1.43 µL 500 mM EDTA 
was added to stop each reaction.
Microarray hybridization and scanning. 
The 16S rRNA­based taxonomic microar­
ray slides (Schott Nexterion AG, Mainz, 
Germany) and probes (positive controls and 
targets) (Eurogentec, Seraing, Belgium) were 
custom designed and synthesized as previ­
ously described (Sanguin et al. 2006a, 2006b). 
Briefly, the microarray included 742 unique 
20mer probes that targeted a broad array of 
bacterial phyla, classes, orders, families, genera, 
and species, and two positive control probes 
that targeted the Eubacteriaceae. The probe 
pattern on the microarray included two spots 
of each of the positive control probes and one 
spot of each of the other probes; this pattern 
was repeated six times on each microarray slide. 
Based on a comparison of experimental and 
theoretical hybridizations, the false­  positive 
and false­negative rates of this microarray sys­
tem have been calculated as 0.91% and 0.81%, 
respectively (Sanguin et al. 2006b).
Labeled and fragmented RNA was pre­
pared in a hybridization mixture yielding a 
final solution of 0.1% SDS, 1X Denhardt’s 
solution (Sigma Chemical Company, St. 
Louis, MO, USA), 6X SSC, and 300 ng RNA. 
Slides were prehybridized, hybridized, and 
washed in an A­Hyb Hybridization Station 
(Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany). Prehybridization was performed at 
57°C for 10 min, hybridization was performed 
at 57°C for 240 min, and a four­step wash 
cycle was performed at 20°C for 4 min. Slides 
were dried by centrifugation in a microcen­
trifuge for 2 min at top speed. Scanning was 
performed using a GenePix Personal 4100A 
scanner (Molecular Devices Corporation, 
Sunnyvale, CA, USA), and data were ana­
lyzed using GenePix Pro 6 Microarray Image 
Analysis (Molecular Devices Corporation).
Data filtration, normalization, and 
  analysis. Filtration, normalization, and 
data analysis were performed using the R 
Project for Statistical Computing (http://
www.r­project.org/). Data filtration and nor­
malization were performed as described by 
Sanguin et al. (2006a). Normalized microar­
ray results for the cigarette samples were com­
pared by principal component analysis (PCA) 
and hierarchical cluster analysis using the ade4 
package (http://pbil.univ­lyon1.fr/ADE­4/).
Figure 1. 16S PCR amplicons (1,500 bp) generated from metagenomic DNA extracted from cigarettes. 
Abbreviations: M, Marlboro Red samples; C, Camel samples; K, Kool Filter King samples; L, Lucky Strike 
Original Red samples; PC, positive control metagenomic DNA sample extracted from soil; NC, negative 
control. Lane 1, DNA ladder. 
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Table 1. Bacterial phyla and classes detected in commonly smoked cigarettes.
Phylum, class
Detected by  
microarray
Detected by  
cloning and sequencing
Actinobacteria, Actinobacteria Yes Yes
Bacteroidetes, Bacteroidetes Yes No
Bacteroidetes, Sphingobacteria Yes Yes
Chloroflexi, Chloroflexi Yes No
Cyanobacteria, Cyanobacteria Yes No
Cyanobacteria, Cyanophyceae Yes No
Deinococcus-Thermus, Thermus Yes No
Firmicutes, Bacilli Yes Yes
Firmicutes, Clostridia Yes No
Planctomycetes, Planctomycetacia Yes No
Proteobacteria, Alphaproteobacteria Yes Yes
Proteobacteria, Betaproteobacteria Yes No
Proteobacteria, Deltaproteobacteria Yes No
Proteobacteria, Gammaproteobacteria Yes Yes
Proteobacteria, Epsilonproteobacteria Yes NoBacterial pathogens present in cigarettes
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Results
All cigarette samples were positive for 16S 
bacterial rRNA (Figure 1) and without excep­
tion, 16S rRNA originating from all samples, 
regardless of brand, hybridized with over 100 
unique microarray probes. Fifteen different 
classes of bacteria were detected in the cigarette 
samples (Table 1). Members of the following 
phyla were detected in nearly all of the sam­
ples: Actinobacteria, Bacteroidetes, Chloroflexi, 
Cyanobacteria, Firmicutes, and Proteobacteria 
(Alphaproteobacteria, Betaproteobacteria, 
Deltaproteobacteria, and Gammaproteobacteria). 
As expected, Nicotiana tabacum 16S chloroplast 
rRNA genes also were detected in every sample.
Our microarray was designed to detect 
microorganisms at both the genus and spe­
cies level. A variety of environmental bacterial 
organisms were identified in all samples, includ­
ing Amaracoccus, Legionellales, Methylobacterium, 
Nostoc, Paracoccus, Pseudomonas chlororaphis, 
and Pseudomonas cichorii, to name a few. A 
broad range of gram­positive and gram­negative 
bacterial genera and species medically important 
to humans and/or potential human pathogens 
were also detected in the cigarette samples 
(Table 2). Most notably, the following organ­
isms were detected in ≥ 90% of all samples: 
Acinetobacter, Bacillus, Burkholderia,Clostridium, 
Klebsiella oxytoca, Pseudomonas, including 
Pseudomonas aeruginosa and Pseudomonas 
stutzeri, and Serratia sp.
As anticipated (DeSantis et al. 2007), the 
cloning and sequencing approach detected 
some but not all of the bacterial organisms 
detected with the microarray (Tables 1 and 
2). Only five bacterial classes were identi­
fied with cloning and sequencing compared 
with 15 classes identified with the microarray 
(Table 1). In addition, only 27 unique bacte­
rial genus or species were identified with clon­
ing and sequencing. Two of these organisms, 
Bacillus spp. and Pseudomonas spp., were also 
detected in cigarettes using the microarray 
approach (Table 2). Other organisms detected 
by cloning and sequencing, but not by the 
micro  array, included Aurantimonas altamirensis, 
Enterococcus gallinarum, and Staphylococcus 
spp. (Table 2), which were not represented by 
probes present on the microarray.
The PCA showed that samples originating 
from the four different cigarette brands were 
not well separated along the first or second 
PCA axes (Figure 2A). In other words, vari­
ability in bacterial diversity between cigarette 
brands was not great, except for a few out­
lying samples (Figures 2A, 3). Nevertheless, 
the hierarchical cluster analysis showed that 
the Marlboro Red and Camel cigarette sam­
ples tended to cluster together, whereas the 
Kool Filter Kings and Lucky Strike Original 
Red cigarette samples were similar to one 
another (Figure 2, Panel B). Microarray 
probes targeting Pseudomonas clusters, 
some Gammaproteobacteria,  and some 
Betaproteobacteria contributed significantly to 
the hybridization patterns observed for the 
Kool Filter Kings and Lucky Strike Original 
Red cigarettes, which distinguished them 
from the Marlboro Red and Camel samples.
Discussion
We explored the bacterial metagenome of 
commercially available cigarettes and revealed 
for the first time that these widely used 
Table 2. Select bacterial genera and species detected in commonly smoked cigarettes that are medically important to humans.
Genus Species
Detected by 
microarray  
(% of samples)
Detected by cloning 
and sequencing  
(% of clones) Potential human health effects
Previously 
detected in 
cigarettes
Acinetobactera Yes (95) No Wide range of illnesses,b from pneumonia to bacteremias No
Atopobiuma Yes (50) No Isolated from a range of infections: periodontal and pelvic abscesses, 
abdominal wounds
No
Aurantimonas A. altamirensis No Yes (1) Isolated from a dendritic corneal ulcer No
Bacillusa Yes (90) Yes (13) Individual species can cause a range of illnesses from foodborne illnesses 
to anthrax
Yes
B. pumilus No Yes (8) Isolated from a central venous catheter infection Yes
Burkholderiaa Yes (90) No Some species can cause pneumonias and bacteremias No
Campylobactera Yes (10) No Etiologic agent of Campylobacteriosis and Guillain-Barre Syndrome No
Chlorogloeopsisa Yes (45) No Type of blue-green algae; potential source of cyanotoxins No
Clostridiuma Yes (90) No Genus includes human pathogens that can cause a wide range of illnesses: 
foodborne illnesses, pneumonias, and bacteremias
No
Comamonas C. testosteroni Yes (15) No Rarely isolated from a range of infections: meningitis, bacteremias, 
endocarditis
No
Corynebacterium C. xerosis Yes (10) No Pneumonia, bacteremias, and skin infectionsb No
Dialistera Yes (5) No Certain species isolated from bacteremias and periodontal disease No
Enterococcus E. gallinarum No Yes (1) Bacteremias, endocarditis, meningitis No
Escherichia E. coli K12 No Yes (1) Commonly used research model in the laboratory; other E. coli strains vary 
from harmless to highly pathogenic
No
Klebsiella K. oxytoca Yes (95) No Pneumonia, neonatal bacteremias, urinary tract infections, abscesses No
Lyngbyaa Yes (45) No A genus of cyanobacteria that causes swimmer’s itch No
Megasphaeraa Yes (20) No Anaerobic bacteria isolated from tonsilloliths and bacterial vaginosis 
infections
No
Microcystisa Yes (10) No Type of blue-green algae; potential source of cyanotoxins No
Novosphingobium N. aromaticivorans No Yes (1) May trigger primary biliary cirrhosis No
Pantoeaa Yes (40) No Some species can cause bacteremias, endocarditis, and wound infections No
Proteusa Yes (30) No Some species can cause urinary tract infections, bacteremias, pneumonias, 
and wound infections
No
Pseudomonasa Yes (100) Yes (3) Some species are human pathogens No
P. aeruginosa/ 
P. stutzeri clusters
Yes (100) No Opportunistic human pathogens that can cause pneumonia, urinary tract 
infections, and bacteremias
No
Serratiaa Yes (95) No Opportunistic human pathogens that can colonize respiratory and urinary tracts No
Staphylococcus S. saprophyticus No Yes (6) Urinary tract infections No
S. epidermidis No Yes (1) Nosocomial pathogen associated with biofilms and foreign bodies No
S. cohnii No Yes (2) Bacteremias, brain abscesses No
S. sciuri No Yes (1) Urinary tract infections, endocarditis, wound infections No
Stenotrophomonas S. maltophilia No Yes (2) Pneumonia, urinary tract infections, bacteremias No
aProbe targeted only the genus level. bParticularly among immunocompromised individuals.Sapkota et al.
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products are characterized by a broad array 
of bacterial diversity. Regardless of brand, 
tested cigarettes harbored numerous gram­
positive and gram­negative bacterial types, 
ranging from soil microorganisms and com­
mensals to potential human pathogens, 
including Acinetobacter, Bacillus, Burkholderia, 
Clostridium, Klebsiella, and Pseudomonas 
aeruginosa (Table 2). Many of the detected 
organisms are capable of causing pneumonia, 
bacteremias, foodborne illnesses, meningitis, 
endocarditis, and urinary tract infections, to 
name a few. For example, P. aeruginosa—a 
bacterium detected in 100% of all cigarette 
samples tested in this study—alone causes 
10% of all hospital­acquired infections in 
the United States and is the leading cause of 
nosocomial pneumonia in both Europe and 
the United States (Bergogne­Berezin 1995).
The identification of Bacillus spp. by 
both our microarray approach and cloning 
and sequencing is consistent with previous 
  culture­based work by both Rooney et al. 
(2005) and Larsson et al. (2008). Rooney 
et al. (2005) identified eight species of Bacillus 
in cigarettes collected from military personnel 
during an investigation of acute eosinophilic 
pneumonitis among individuals who had been 
deployed during Operation Iraqi Freedom. 
Larsson et al. (2008) recovered Bacillus spp., 
including Bacillus subtilis, from fresh tobacco 
leaves collected at a tobacco­manufacturing 
plant. Bacillus spp. have also been identified 
in cured tobacco leaves (Kaelin and Gadani 
2000), stored tobacco (Kaelin et al. 1994), 
dead tobacco beetles (Kaelin et al. 1994), and 
chewing tobacco sold in the United States 
(Rubinstein and Pedersen 2002).
In addition to Bacillus spp., a few of the 
other species detected by our microarray 
approach including Pantoea spp., Acinetobacter 
spp., Pseudomonadaceae spp., and members of 
the Enterobacteriaceae family were recently 
detected in a study by Larsson et al. (2008) 
that investigated microbiological components 
of fresh tobacco leaves using culture methods. 
These investigators identified the following 
bacterial species in fresh tobacco leaves using 
blood agar, eosin methylene blue agar, and 
half­strength tryptic soy agar: Pantoea agglom-
erans, Acinetobacter calco  aceticus, and specific 
Pseudomonadaceae species such as P. fluore-
scens and Stenotrophomonas maltophilia. As out­
lined in Table 2, we also detected Pantoea spp., 
Acinetobacter spp. and Stenotrophomonas malto-
philia in cigarette tobacco, along with other 
specific Pseudomonadaceae species including 
P. aeruginosa and P. stutzeri. Furthermore, 
Larsson et al. (2008) detected some members 
of the Enterobacteriaceae family such as E. 
amnigenus and E. cancerogenus. Although we 
did not detect these organisms, because probes 
for these species were not included in our 
microarray, we did detect other members of 
this gram­negative family including Klebsiella 
oxytoca and E. coli.
The findings that Larsson et al. (2008) were 
able to culture a few of the same organisms from 
fresh tobacco leaves that we detected in com­
mercially available cigarettes provides evidence 
that cigarette tobacco may be contaminated 
with bacteria early in the production process, 
possibly at the farm level, and that the organ­
isms are likely able to survive the manufactur­
ing process, including the curing process, and 
remain present in consumer­ready cigarettes. 
Moreover, the fact that Larsson et al. (2008) 
used fairly non  specific culture media and were 
subsequently able to identify some of the same 
organisms that we detected provides intriguing 
support for the idea that many other organisms 
that we detected via microarray also could be 
cultured if more selective media are used in 
future culture­based studies of cigarettes.
One other previous study cultured bac­
teria from single tobacco flakes recovered 
from commercially available cigarettes, as 
well as fine tobacco dust that potentially 
could be inhaled into deeper regions of the 
lungs (Pauly et al. 2008). These researchers 
observed that 92.9% of tobacco flakes repre­
senting eight different cigarette brands were 
positive for bacterial growth after 24 hr. In 
addition, 90% of tobacco dust samples tested 
positive for bacterial growth. Although these 
researchers did not identify the specific bacte­
rial species that were isolated, their findings 
provide additional evidence that cigarettes are 
widely contaminated with bacteria and that 
the organisms are viable.
Important questions remain, how­
ever, regarding the implications of bacteria­
  harboring cigarettes. Can bacteria present in 
cigarettes survive the burning/smoking pro­
cess, be inhaled by smokers and other exposed 
individuals, and colonize the lungs? In a study 
by Eaton et al. (1995), the authors recovered 
Mycobacterium avium from smoked cigarette 
Figure 2. Hybridization pattern analysis of bacterial diversity in four brands of cigarettes performed by PCA (A) and hierarchical cluster analysis (B). In Panels 
A and B, the letters within the sample codes represent the following cigarette brands: M, Marlboro Red; C, Camel; K, Kool Filter Kings; and L, Lucky Strike 
Original Red.
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filters, providing evidence that these micro­
organisms can survive in the presence of high 
temperatures and gases generated by a lit ciga­
rette (Eaton et al. 1995). Thus, it is possible 
that other organisms, particularly the hardy 
endospore formers including Bacillus spp. 
and Clostridium spp. identified in the present 
study, also could survive the harsh conditions 
of the cigarette burning/smoking process. 
However, beyond the Eaton et al. (1995) 
study, no researchers to our knowledge have 
investigated the survival of other bacterial spe­
cies in smoked cigarettes. This is a very impor­
tant future avenue of research that needs to be 
investigated to fully understand the potential 
public health implications of bacterial patho­
gens present in cigarettes. On the other hand, 
Pauly et al. (2008) demonstrated that bacteria 
can even be cultured from fine tobacco pow­
der present in commercially available ciga­
rettes. Therefore, it is possible that bacteria 
associated with these fine particles could pass 
through cigarette filters currently used (Pauly 
et al. 2002) and be inhaled into the lungs even 
after the first few puffs of a cigarette, when the 
majority of the cigarette remains at low tem­
peratures. Moreover, because tobacco flakes 
and particles are often observed on the tips of 
cigarette filters (Pauly et al. 2008) and sub­
sequently brought into the mouth, it is pos­
sible that bacterial organisms present in the 
cigarette could be transferred to the mouths of 
smokers even before the cigarette is lit.
In terms of the cigarette smoke itself, the 
microbiology of this complex mixture has 
not been studied comprehensively. To date, 
most studies concerning microbiological com­
ponents of cigarette smoke have focused on 
endotoxins (Barnes and Glantz 2007; Hasday 
et al. 1999; Larsson et al. 2004; Reiman and 
Uitti 2000; Rennie et al. 2008; Sebastian et al. 
2006; Thorne et al. 2009). Hasday et al. (1999) 
demonstrated for the first time that both 
mainstream and sidestream cigarette smoke 
contain significant levels of bioactive bacterial 
endotoxin (ranging from 18 ± 1.5 ng/cigarette 
to 120 ± 64 ng/cigarette). Since then, other 
groups have shown that smoking indoors sig­
nificantly increases indoor air endotoxin con­
centrations in experimental settings (Larsson 
et al. 2004), as well as in homes (Rennie et al. 
2008; Sebastian et al. 2006). In addition to 
endotoxins, Larsson et al. (2008) recently 
showed that elevated levels of muramic acid, a 
peptidoglycan marker that can serve as an indi­
cator of gram­positive bacteria, are also pres­
ent in tobacco smoke. However, beyond these 
bacterial markers, very little work has been 
performed to evaluate whole, viable, particle­
  associated bacterial cells that may be aerosolized 
in tobacco smoke, and this is certainly an excit­
ing potential avenue for future research.
If viable bacterial cells are ultimately 
detected in tobacco smoke, then they would 
have to subsequently colonize exposed indi­
viduals to cause health effects. Although data 
on the bacterial diversity of tobacco smoke 
are not available, previous studies have shown 
that active smoking and exposure to second­
hand smoke are associated with colonization 
by potentially pathogenic bacteria (Brook and 
Gober 2005, 2008; Shiloah et al. 2000) and an 
increased risk of acute bacterial lung infections 
(Aronson et al. 1982). The naso  pharyngeal and 
oral flora of smokers and children of smokers 
is characterized by more bacterial pathogens 
compared with that of nonsmokers and their 
children (Brook and Gober 2005, 2008). In 
fact, smokers are 18 times more likely to har­
bor bacterial pathogens in the oral cavity com­
pared with nonsmokers (Shiloah et al. 2000). 
In addition, the elevated number of pathogens 
in the naso  pharyngeal cavities of smokers has 
been shown to revert to normal levels observed 
in nonsmokers after complete smoking cessa­
tion (Brook and Gober 2007).
Our findings provide intriguing evidence 
that the source of pathogenic organisms in 
smokers (and those impacted by secondhand 
smoke) may be the cigarettes themselves. 
However, it is important to note that some 
bacterial organisms recovered from smokers 
commonly colonize the nasopharynx, and 
increased susceptibility to colonization, as 
well as the increased risk of lung infections 
associated with smoking, could be due to 
immuno  suppressive activities by chemicals and 
particulate matter present in cigarette smoke. 
Long­term smokers may have less­effective 
mucociliary clearance mechanisms (Wanner 
et al. 1996), chronic inflammation of the lungs 
(Yanbaeva et al. 2007), and compromised host 
defense mechanisms (Birrell et al. 2008), all 
of which could contribute to higher levels 
of colonization. Future work is necessary to 
determine possible interactions or synergisms 
between colonization that may result because 
of immunosuppressive effects and colonization 
that may occur as a result of the introduction 
of organisms from external sources.
Beyond the issue of bacterial colonization 
and acute respiratory illnesses, another avenue 
to explore is whether bacteria in cigarettes could 
also contribute to human carcinogenesis. The 
role of microbes in the development of some 
human cancers is being explored (Correa 2003; 
Hohenberger and Gretschel 2003; Parsonnet 
1995). Although the specific microbes identi­
fied as the causative agents in these cancers have 
not been detected in tobacco products, further 
studies are needed to understand whether bac­
teria originating from cigarettes could contrib­
ute to carcinogenesis either through biologically 
mediated pathways or through biological and 
chemical interactions. Recently, Hunter et al. 
(2005) showed that Bacillus subtilis, which was 
detected in 90% of our cigarette samples, is 
a possible degrader of pyrene and benzo[a]
pyrene, major chemical carcinogens found in 
Figure 3. Distribution of select bacteria of importance to human health detected in different cigarette brands using a 16S rRNA-based taxonomic microarray.
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cigarettes (Hunter et al. 2005). Although it is 
unclear at this time whether the metabolites 
resulting from the degradation of these com­
pounds by B. subtilis are more toxic than their 
parent compounds (Hunter et al. 2005), it is 
worthwhile to note that bacteria—including 
Bacillus and others that may be deposited in 
the lungs as a result of cigarette smoking—
could alter cigarette­associated chemicals into 
greater or lesser carcinogens.
One limitation to this study is that the 
microarray platform used was primarily devel­
oped to explore bacterial diversity in environ­
mental samples. Therefore, the probes present 
on the microarray slides more heavily repre­
sented soil and water microorganisms versus 
potential human pathogens, such as those 
included in the Enterobacteriaceae family. 
The implication of this limitation is that there 
could be even more potential bacterial patho­
gens present in the cigarette samples com­
pared with the number that we detected with 
our current microarray system.
Another limitation of this study is that we 
analyzed cigarette tobacco alone and did not 
include analyses of cigarette smoke. Future 
studies are necessary to fully characterize the 
microbiology of cigarette smoke. Beyond the 
smoke, additional studies will be necessary to 
determine whether organisms present in the 
cigarettes and smoke can colonize smokers and 
other exposed individuals and ultimately cause 
human illnesses.
Conclusions
Nearly every scientific paper concerning the 
acute human health effects associated with 
cigarette smoking mentions that smoking is 
associated with increases in bacterial infec­
tions among smokers. However, to our knowl­
edge no one has comprehensively evaluated 
whether the actual cigarettes themselves may 
be the source of exposure to bacterial organ­
isms that subsequently cause infection and 
other potential illnesses. Here we describe that 
multiple brands of cigarettes are rich in bacte­
rial diversity, harboring a broad array of micro­
organisms from environmental bacteria and 
commensals to potential human pathogens. 
The overall public health implications of these 
findings are unclear at this time, and future 
studies are necessary to determine whether 
microbes originating from cigarettes could 
play a considerable role in the development 
of both infectious and chronic diseases among 
smokers and other exposed populations.
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